Literature DB >> 19878743

Identification of gene copy number variations in patients with mental retardation using array-CGH: Novel syndromes in a large French series.

Sylvie Jaillard1, Séverine Drunat, Claude Bendavid, Azzedine Aboura, Amandine Etcheverry, Hubert Journel, Andrée Delahaye, Laurent Pasquier, Dominique Bonneau, Annick Toutain, Lydie Burglen, Agnès Guichet, Eva Pipiras, Brigitte Gilbert-Dussardier, Brigitte Benzacken, Dominique Martin-Coignard, Catherine Henry, Albert David, Josette Lucas, Jean Mosser, Véronique David, Sylvie Odent, Alain Verloes, Christèle Dubourg.   

Abstract

Array-CGH has revealed a large number of copy number variations (CNVs) in patients with multiple congenital anomalies and/or mental retardation (MCA/MR). According to criteria recently listed, pathogenicity was clearly suspected for some CNVs but benign CNVs, considered as polymorphisms, have complicated the interpretation of the results. In this study, genomic DNAs from 132 French patients with unexplained mental retardation were analysed by genome wide high-resolution Agilent 44K oligonucleotide arrays. The results were in accordance with those observed in previous studies: the detection rate of pathogenic CNVs was 14.4%. A non-random involvement of several chromosomal regions was observed. Some of the microimbalances recurrently involved regions (1q21.1, 2q23.1, 2q32q33, 7p13, 17p13.3, 17p11.2, 17q21.31) corresponding to known or novel syndromes. For all the pathogenic CNVs, further cases are needed to allow more accurate genotype-phenotype correlations underscoring the importance of databases to group patients with similar molecular data. Copyright 2009 Elsevier Masson SAS. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19878743     DOI: 10.1016/j.ejmg.2009.10.002

Source DB:  PubMed          Journal:  Eur J Med Genet        ISSN: 1769-7212            Impact factor:   2.708


  14 in total

1.  Proximal microdeletions and microduplications of 1q21.1 contribute to variable abnormal phenotypes.

Authors:  Jill A Rosenfeld; Ryan N Traylor; G Bradley Schaefer; Elizabeth W McPherson; Blake C Ballif; Eva Klopocki; Stefan Mundlos; Lisa G Shaffer; Arthur S Aylsworth
Journal:  Eur J Hum Genet       Date:  2012-02-08       Impact factor: 4.246

2.  The Koolen-de Vries syndrome: a phenotypic comparison of patients with a 17q21.31 microdeletion versus a KANSL1 sequence variant.

Authors:  David A Koolen; Rolph Pfundt; Katrin Linda; Gea Beunders; Hermine E Veenstra-Knol; Jessie H Conta; Ana Maria Fortuna; Gabriele Gillessen-Kaesbach; Sarah Dugan; Sara Halbach; Omar A Abdul-Rahman; Heather M Winesett; Wendy K Chung; Marguerite Dalton; Petia S Dimova; Teresa Mattina; Katrina Prescott; Hui Z Zhang; Howard M Saal; Jayne Y Hehir-Kwa; Marjolein H Willemsen; Charlotte W Ockeloen; Marjolijn C Jongmans; Nathalie Van der Aa; Pinella Failla; Concetta Barone; Emanuela Avola; Alice S Brooks; Sarina G Kant; Erica H Gerkes; Helen V Firth; Katrin Õunap; Lynne M Bird; Diane Masser-Frye; Jennifer R Friedman; Modupe A Sokunbi; Abhijit Dixit; Miranda Splitt; Mary K Kukolich; Julie McGaughran; Bradley P Coe; Jesús Flórez; Nael Nadif Kasri; Han G Brunner; Elizabeth M Thompson; Jozef Gecz; Corrado Romano; Evan E Eichler; Bert B A de Vries
Journal:  Eur J Hum Genet       Date:  2015-08-26       Impact factor: 4.246

3.  Homozygous Truncating Intragenic Duplication in TUSC3 Responsible for Rare Autosomal Recessive Nonsyndromic Intellectual Disability with No Clinical or Biochemical Metabolic Markers.

Authors:  S El Chehadeh; C Bonnet; P Callier; M Béri; T Dupré; M Payet; C Ragon; A L Mosca-Boidron; N Marle; F Mugneret; A Masurel-Paulet; J Thevenon; N Seta; L Duplomb; P Jonveaux; L Faivre; C Thauvin-Robinet
Journal:  JIMD Rep       Date:  2015-01-28

4.  Evolutionary history and genome organization of DUF1220 protein domains.

Authors:  Majesta S O'Bleness; C Michael Dickens; Laura J Dumas; Hildegard Kehrer-Sawatzki; Gerald J Wyckoff; James M Sikela
Journal:  G3 (Bethesda)       Date:  2012-09-01       Impact factor: 3.154

5.  Single exon-resolution targeted chromosomal microarray analysis of known and candidate intellectual disability genes.

Authors:  Tracy Tucker; Farah R Zahir; Malachi Griffith; Allen Delaney; David Chai; Erica Tsang; Emmanuelle Lemyre; Sylvia Dobrzeniecka; Marco Marra; Patrice Eydoux; Sylvie Langlois; Fadi F Hamdan; Jacques L Michaud; Jan M Friedman
Journal:  Eur J Hum Genet       Date:  2013-11-20       Impact factor: 4.246

6.  Exome sequencing and arrayCGH detection of gene sequence and copy number variation between ILS and ISS mouse strains.

Authors:  Laura Dumas; C Michael Dickens; Nathan Anderson; Jonathan Davis; Beth Bennett; Richard A Radcliffe; James M Sikela
Journal:  Mamm Genome       Date:  2014-02-20       Impact factor: 2.957

7.  Validation and implementation of array comparative genomic hybridisation as a first line test in place of postnatal karyotyping for genome imbalance.

Authors:  Joo Wook Ahn; Kathy Mann; Sally Walsh; Marwa Shehab; Sarah Hoang; Zoe Docherty; Shehla Mohammed; Caroline Mackie Ogilvie
Journal:  Mol Cytogenet       Date:  2010-04-15       Impact factor: 2.009

8.  MLPA for confirmation of array CGH results and determination of inheritance.

Authors:  Alison Hills; Joo Wook Ahn; Celia Donaghue; Helen Thomas; Kathy Mann; Caroline Mackie Ogilvie
Journal:  Mol Cytogenet       Date:  2010-10-13       Impact factor: 2.009

9.  Macrocephaly as a clinical indicator of genetic subtypes in autism.

Authors:  Steven Klein; Pantea Sharifi-Hannauer; Julian A Martinez-Agosto
Journal:  Autism Res       Date:  2013-01-29       Impact factor: 5.216

10.  Prenatal ultrasound findings in Koolen-de Vries foetuses: Central nervous system anomalies are frequent markers of this syndrome.

Authors:  Fe Amalia García-Santiago; Cristina Martínez-Payo; Elena Mansilla; Fernando Santos-Simarro; Miguel Ruiz de Azua Ballesteros; María Ángeles Mori; Eugenia Antolín Alvarado; Yolanda Nieto; Isabel Vallcorba; Jair Tenorio; Julián Nevado; Pablo Lapunzina
Journal:  Mol Genet Genomic Med       Date:  2021-03-18       Impact factor: 2.183

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.